Alto Neuroscience, Inc. (ANRO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$33.45M2024: -$47.42M2025: -$51.77M-$51.77M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$51.77M-9.2%
2024-$47.42M-41.8%
2023-$33.45M